Annual Report 2003
Highlights of the Year
Sales Overview
Product Lines
Chairman's Letter
Chief Executive's Letter
Success Stories
Related Links
Home
Contact Us
Order Publications
 HIGHLIGHTS OF THE YEAR
 
 

Financial Highlights            
    Excluding Restructuring
and Impairment4
  Including Restructuring
and Impairment4
  2003
$m
2002
$m
Actual
%
CER1
%
2003
$m
2002
$m
Sales 6578 6197 +6 -1 6578 6197
EBITDA5 1219 1154 +6 +4    
Net Income 363 265 +37   268 (27)
Earnings per Share $3.56 $2.61 +36   $2.63 $(0.26)
Recommended Dividend per Share CHF 1.70 CHF 0.85        


  Sales up six per cent to $6.6 billion, -1% CER1; growth in second half +2% CER1
  New product sales of half a billion dollars
  Earnings per share2 up 36 per cent to $3.56
  Free cash flow3 $562 million: dividend doubled to CHF 1.70
  Operational efficiency program: further $300 million annual savings by 2008
 

Progressive dividend plus share repurchase: more than $800 million return to shareholders planned over three years

 

1  Growth at constant exchange rates (CER). For full description see financial information.
2 EPS on a fully-diluted basis is before restructuring and impairment.
3 For a definition of free cash flow see financial information.
4 The amounts including restructuring and impairment are reported in accordance with International Financial Reporting Standards (IFRS). The impact of these charges in 2003 is $95m (2002: $292m) on net income and $0.93 (2002: $2.87) on earnings per share.
5 EBITDA is a non-GAAP measure in regular use as a measure of gross cash flow generation. For a definition see financial information.
6 Excluding the impact of range rationalization. For more details see financial information.



Advanced Search Cautionary Statement
spacer spacer
©2004 Syngenta. All rights reserved.
Deutsch Terms & Conditions Privacy Statement Site Tips Site Map